Literature DB >> 3973985

Virus-receptor interaction in the adenovirus system: characterization of the positive cooperative binding of virions on HeLa cells.

R Persson, C Wohlfart, U Svensson, E Everitt.   

Abstract

The established positive cooperativity of adenovirus 2 binding to HeLa cells revealed a strong temperature dependence. The degree of cooperativity, quantified by means of Hill coefficients, progressively increased from 10 degrees C to reach a maximum level, which was maintained between 20 and 37 degrees C. On the other hand, negative cooperativity of virion attachment was apparent at 3.0 degrees C and on glutaraldehyde-stabilized cells. The corresponding monovalent ligand of the system, the fiber antigen, demonstrated only weak-positive cooperativity of the binding at 37.0 degrees C, which was absent at 3.0 degrees C. Dithiothreitol and dansylcadaverine, reagents inhibiting clustering of ligand-receptor complexes in the plasma membrane, markedly reduced the degree of positive cooperative binding at 37.0 degrees C. Evidently, the positive cooperative binding of adenovirus to HeLa cells at 37.0 degrees C is a consequence of both the multivalency of virus attachment proteins, i.e., fibers, on the virion and of the capacity of the receptor sites to migrate in the plane of the plasma membrane, forming local aggregates of virus-receptor site complexes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973985      PMCID: PMC254765     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cells.

Authors:  E Hazum; K J Chang; P Cuatrecasas
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

2.  Scatchard plots.

Authors:  I H Scheinberg
Journal:  Science       Date:  1982-01-15       Impact factor: 47.728

3.  Cooperativity of lectin binding to lymphocytes, and its relevance to mitogenic stimulation.

Authors:  A Prujansky; A Ravid; N Sharon
Journal:  Biochim Biophys Acta       Date:  1978-03-21

4.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

5.  Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self-aggregation in hormone action.

Authors:  Y Shechter; K J Chang; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Synthesis and processing of the precursor to the major core protein of adenovirus type 2.

Authors:  E Everitt; S A Meador; A S Levine
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

7.  Simulation of association curves and 'Scatchard' plots of binding reactions where ligand and receptor are degraded or internalized.

Authors:  J S Beck; H J Goren
Journal:  J Recept Res       Date:  1983

8.  Molecular weight of adenovirus serotype 2 capsomers. A new characterization.

Authors:  C Devaux; M Zulauf; P Boulanger; B Jacrot
Journal:  J Mol Biol       Date:  1982-04-25       Impact factor: 5.469

9.  Local aggregation of hormone-receptor complexes is required for activation by epidermal growth factor.

Authors:  Y Schechter; L Hernaez; J Schlessinger; P Cuatrecasas
Journal:  Nature       Date:  1979-04-26       Impact factor: 49.962

10.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more
  25 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Structural and functional determinants in adenovirus type 2 penton base recombinant protein.

Authors:  L Karayan; S S Hong; B Gay; J Tournier; A D d'Angeac; P Boulanger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection.

Authors:  J Zabner; P Freimuth; A Puga; A Fabrega; M J Welsh
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

Authors:  C Defer; M T Belin; M L Caillet-Boudin; P Boulanger
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

Review 6.  Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

Authors:  T Pencavel; R Seth; A Hayes; A Melcher; H Pandha; R Vile; K J Harrington
Journal:  Gene Ther       Date:  2010-05-06       Impact factor: 5.250

7.  Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection.

Authors:  J Horvath; J M Weber
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells.

Authors:  S S Hong; L Karayan; J Tournier; D T Curiel; P A Boulanger
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

9.  Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli.

Authors:  L J Henry; D Xia; M E Wilke; J Deisenhofer; R D Gerard
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.